Proffitt & Goodson Inc. Sells 113 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Proffitt & Goodson Inc. lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 6,946 shares of the financial services provider’s stock after selling 113 shares during the period. Proffitt & Goodson Inc.’s holdings in iShares Biotechnology ETF were worth $918,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $29,000. HHM Wealth Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares during the period. Bradley & Co. Private Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $32,000. Newbridge Financial Services Group Inc. bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $137.03 on Friday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The business has a 50 day moving average of $135.82 and a 200-day moving average of $140.68.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.